Federal officials on Wednesday said they anticipate vaccinating as many as 100 million people by March once a coronavirus vaccine is approved and ready to be distributed.

In a call with reporters, HHS Secretary Alex Azar said federal agencies have made preparations to begin allocating a vaccine, or vaccines, immediately after the U.S. Food and Drug Administration grants emergency use authorization for use.

Among the most likely candidates to gain FDA approval first include vaccines developed by makers Pfizer and BioNTech, which won approval for use in Britain on Wednesday, as well as one developed by Moderna.

The FDA’s vaccine advisory committee is scheduled to review the Pfizer and BioNTech vaccine on Dec. 10, with Moderna’s candidate scheduled for review on Dec. 17.

“We’re on

Read More At Article Source | Article Attribution